Lv5
976 积分 2025-03-13 加入
The global patent landscape of bispecific antibodies: technological innovations and therapeutic applications
1个月前
已完结
Development of Sensitive Immunoassays for Free and Total Human Glandular Kallikrein 2
3个月前
已完结
Targeting ALPPL2 with a novel CD89 bispecific antibody reprograms macrophages to enhance anti-tumor immunity
4个月前
已完结
In silico identification and experimental validation of long-range allosteric inhibition of Staphylococcus aureus Cas9 catalytic activity by an anti-CRISPR protein AcrIIA14
5个月前
已完结
KRAS mutation-driven O-GlcNAcylation of CLDN18.2 enhances the progression of pancreatic cancer and reduces the efficacy of CLDN18.2-targeted therapy
5个月前
已完结
Structural and functional insights into CD3 bispecific antibodies targeting DLL3 in cancer immunotherapy
5个月前
已完结
A soluble form of the adhesion receptor CD58 (LFA‐3) is present in human body fluids
5个月前
已完结
Monoclonal antibody and ligand binding sites of the T cell erythrocyte receptor (CD2)
5个月前
已完结
TIGIT’s immuno-oncology teachings
6个月前
已完结
Characterization of an anti-STEAP1 T-Cell Dependent Bispecific Antibody for the Treatment of Prostate Cancer and Associated Toxicity in Cynomolgus Monkeys
6个月前
已完结
皖公网安备34019202002308
